Skip to main content
SpringerLink
Log in

Mycobacterium tuberculosis

  • Chapter
Opportunistic Infections

Part of the book series: Infectious Disease ((ID))

  • 179 Accesses

Abstract

Pulmonary tuberculosis (consumption, phthisis) is considered to be one of the most devastating human diseases causing death and prolonged disability among people over many centuries. Following a decline in the prevalence during the latter part of the 20th century, the incidence of tuberculosis has substantially risen in recent years (1,2). Currently, Mycobacterium tuberculosis is the greatest single infectious cause of mortality worldwide, causing the death of approximately two million people annually. This, coupled with the AIDS pandemic and the surge in multidrug-resistant clinical isolates of M. tuberculosis, have reaffirmed tuberculosis as a primary public health threat.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fry, D. E. The reemergence of mycobacterial infections. Arch. Surg., 131, 14, 1996.

    Article  PubMed  CAS  Google Scholar 

  2. Peloquin, C. A. and Berning, S. E. Infection caused by Mycobacterium tuberculosis. Ann. Pharmacother., 28, 72, 1994.

    CAS  Google Scholar 

  3. Yencha, M. W., Linfesty, R., and Blackmon, A. Laryngeal tuberculosis. Am. J. Otolaryngol., 21, 122–126, 2000.

    Article  CAS  Google Scholar 

  4. Labhard, N., Nicod, L., and Zellweger, J. P. Cerebral tuberculosis in the immunocompetent host: 8 cases observed in Switzerland. Tuber. Lung Dis., 75, 454, 1994.

    Article  PubMed  CAS  Google Scholar 

  5. Yalcinkaya, F., Tumer, N., Akar, N., Ekim, M., and Bildirici, Y. Tuberculous osteomyelitis: an unusual case of tuberculous infection in a child undergoing continuous ambulatory peritoneal dialysis. Pediatr. Nephrol., 9, 485, 1995.

    Article  PubMed  CAS  Google Scholar 

  6. Weiler, Z., Nelly, P., Baruchin, A. M., and Oren, S. Diagnosis and treatment of cervical tuberculous lymphadenitis. J. Oral Maxillofac. Surg., 58, 477–481, 2000.

    Article  PubMed  CAS  Google Scholar 

  7. Huebner, R. E. and Castro, K. G. The changing face of tuberculosis. Annu. Rev. Med., 46, 47, 1995.

    Article  PubMed  CAS  Google Scholar 

  8. Park, S. B., Joo, I., Park, Y. I., et al. Clinical manifestations of tuberculosis in renal transplant patients. Transplant. Proc., 28, 1520, 1996.

    PubMed  CAS  Google Scholar 

  9. Munoz, P., Palomo, J., Munoz, R., Rodriguez-Creixems, M., Pelaez, T., and Bouza, E. Tuberculosis in heart transplant recipients. Clin. Infect. Dis., 21, 398, 1995.

    Article  PubMed  CAS  Google Scholar 

  10. Ahsan, N., Blanchard, R. L., and Mai, M. L. Gastrointestinal tuberculosis in renal transplantation. Clin. Transplant, 9, 349, 1995.

    PubMed  CAS  Google Scholar 

  11. Miller, R. A., Lanza, L. A., Kline, J. N., and Geist, L. J. Mycobacterium tuberculosis in lung transplant recipients. Am. J. Respir. Crit. Care Med., 152, 374, 1995.

    PubMed  CAS  Google Scholar 

  12. Tantawichien, T., Suwangool, P., and Suvanapha, R. Tuberculosis in renal transplant recipients. Transplant. Proc., 26, 2187, 1994.

    PubMed  CAS  Google Scholar 

  13. Chen, C. H., Hsieh, H., and Lai, M. K. Pulmonary tuberculosis or MOT’ infection in kidney transplant recipients. Transplant. Proc., 26, 2136, 1994.

    PubMed  CAS  Google Scholar 

  14. Anders, N. and Wollensak, G. Ocular tuberculosis in systemic lupus erythematosus and immunosuppressive therapy. Klin. Monatsbl. Augenheilkd., 207, 368, 1995.

    Article  PubMed  CAS  Google Scholar 

  15. Neukirch, B. and Kremer, G. J. Disseminated extrapulmonary tuberculosis in idiopathic CD4-lymphocytopenia. Dtsch. Med. Wochenschr., 120, 23, 1995.

    Article  PubMed  CAS  Google Scholar 

  16. Nagasawa, M., Maeda, H., Okawa, H., and Yata, J. Pulmonary miliary tuberculosis and T- cell abnormalities in a severe combined immunodeficient patient reconstituted with haploidentical bone marrow transplantation. Int. J. Hematol., 59, 303, 1994.

    PubMed  CAS  Google Scholar 

  17. Phair, J. P., Gross, P. A., Kaplan, J. E., et al. Quality standard for the identification and treatment of persons coinfected with human immunodeficiency virus and Mycobacterium tuberculosis. Clin. Infect. Dis., 21 (Suppl. 1), S130, 1995.

    Google Scholar 

  18. Molina-Gamboa, J. D., Ponce-de-Leon, S., Sifuentes-Osornio, J., Bobadilla del Valle, M., and Ruiz-Palacios, G. M. Mycobacterial infection in Mexican AIDS patients. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 11, 53, 1996.

    Article  PubMed  CAS  Google Scholar 

  19. Drobniewski, F. A., Pozniak, A. L., and Uttley, A. H. Tuberculosis and AIDS. J. Med. Microbiol., 43, 85, 1995.

    Article  PubMed  CAS  Google Scholar 

  20. Kritski, A., Dalcolmo, M., del Bianco, R., et al. Association of tuberculosis and HIV infection in Brasil. Bol. Oficina Sanit. Panam., 118, 542, 1995.

    PubMed  CAS  Google Scholar 

  21. Waxman, S., Gang, M., and Goldfrank, L. Tuberculosis in the HIV-infected patient. Emerg. Med. Clin. North Am., 13, 179, 1995.

    CAS  Google Scholar 

  22. Farley, T. A. AIDS and multidrug-resistant tuberculosis: an epidemic transforms an old disease. J. La. State Med. Soc., 144, 357, 1992.

    PubMed  CAS  Google Scholar 

  23. Bagg, J. Tuberculosis: a re-emerging problem for health care workers. Br. Dent. J., 180, 376, 1996.

    Article  PubMed  CAS  Google Scholar 

  24. Moroni, M., Gori, A., Rusconi, S., Franzetti, F., and Antinori, S. Mycobacterial infections in AIDS: an overview of epidemiology, clinical manifestations, therapy and prophylaxis. Monaldi Arch. Chest Dis., 49, 432, 1994.

    PubMed  CAS  Google Scholar 

  25. Fraser, V. J., Kilo, C. M., Bailey, T. C., Medoff, G., and Dunagan, W. C. Screening of physicians for tuberculosis. Infect. Control Hosp. Epidemioi., 15, 95, 1994.

    Article  CAS  Google Scholar 

  26. Pearson, M. L., Jereb, J. A., Frieden, T. R., et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: a risk to patients and health care workers. Ann. Intern. Med., 117, 191, 1992.

    PubMed  CAS  Google Scholar 

  27. Githui, W., Nunn, P., Juma, E., et al. Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results. Tuber. Lung Dis., 73, 203, 1992.

    Article  PubMed  CAS  Google Scholar 

  28. Allen, S., Batungwanayo, J., Kerlikowske, K., et al. Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. Am. Rev. Respir. Dis., 146, 1439, 1992.

    PubMed  CAS  Google Scholar 

  29. Daley, C. L., Small, P. M., Schecter, G. F., et al. An outbreak of tuberculosis with accelerated progression among persons infected with HIV. N. Engl. J. Med., 326, 231, 1992.

    Article  PubMed  CAS  Google Scholar 

  30. Churchyard, G. J. and Grant, A. D. HIV infection, tuberculosis and non-tuberculous mycobacteria. S. Afr. Med. J., 90, 472–476, 2000.

    PubMed  CAS  Google Scholar 

  31. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Management of opportunistic mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Thorax, 55, 210–218, 2000 [see also: Thorax, 55, 722, 2000 ]

    Article  Google Scholar 

  32. Chiu, C. P., Wong, W. W., Kuo, B., Tiao, T. M., Fung, C. P., and Liu, C. Y. Clinical analysis of Mycobacterium tuberculosis infection in patients with acquired immunodeficiency syndrome. J. Microbiol. Immunol. Infect., 32, 250256, 1999.

    Google Scholar 

  33. Perlman, D. C., El-Helon, P., and Salomon, NTuberculosis in patients with human immunodeficiency virus infection. Semin. Respir. Infect.,14, 344–352, 1999.

    Google Scholar 

  34. Zumla, A., Malon, P., Henderson, J., and Grange, J. M., Impact of HIV infection on tuberculosis. Postgrad. Med. J., 76, 259–268, 2000.

    Article  PubMed  CAS  Google Scholar 

  35. Shafer, R. W. and Edlin, B. R., Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin. Infect. Dis., 22, 683, 1996.

    Article  PubMed  CAS  Google Scholar 

  36. Wada, M., Yamamoto, S., Ogata, H., Sugita, N., Kino, T., and Hayashi, A. Two pulmonary tuberculosis cases with HIV infection. Kekkaku, 69, 367, 1994.

    PubMed  CAS  Google Scholar 

  37. Jones, E., Young, S. M. M., Antoniskis, D., Davidson, P. T., Kramer, F., and Barnes, P. F. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infections. Am. Rev. Respir. Dis., 148, 1292, 1993.

    CAS  Google Scholar 

  38. Dupon, M., Texier-Maugein, J., Leroy, V., et al. Tuberculosis and HIV infection: a cohort study of incidence and susceptibility to antituberculous drugs, Bordeaux, 1985–1993. AIDS, 9, 577, 1995.

    Article  PubMed  CAS  Google Scholar 

  39. Greten, T., Hautmann, H., Trauner, A., and Huber, R. M. Esophagomediastinal fistulae as a rare complication of tuberculosis in an HIV-infected patient. Dtsch. Med. Wochenschr., 119, 1613, 1994.

    Article  PubMed  CAS  Google Scholar 

  40. Corbett, E. L., Crossley, I., De Cock, K. M., and Miller, R. F. Disseminated cutaneous Mycobacterium tuberculosis infection in a patient with AIDS. Genitourin. Med.71, 308, 1995.

    Google Scholar 

  41. Berenguer, J., Moreno, S., Laguna, F., et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N. Engl. J. Med., 326, 668, 1992.

    Article  PubMed  CAS  Google Scholar 

  42. Fortun, J., Gomez-Mampaso, E., Navas, E., Hermida, C. M., Antela, A., and Guerrero, A. Tuberculous meningitis caused by resistant microorganisms. Enferm. Infecc. Microbiol. Clin., 12, 150, 1994.

    PubMed  CAS  Google Scholar 

  43. Moreno, S., Baraia, J., Parras, F., Solera, J., Bernacer, B., Meana, A., and Bouza, E. Fever evolution after treatment in patients with tuberculosis and HIV infection. Rev. Clin. Esp., 195, 150, 1995.

    PubMed  CAS  Google Scholar 

  44. Albrecht, H., Stelbrink, H. J., Eggers, C., Rusch-Gerdes, S., and Greten, H. A case of disseminated Mycobacterium bovis infection in an AIDS patient. Eur. J. Clin. Microbiol. Infect. Dis.14, 226, 1995.

    Google Scholar 

  45. Calpe, J. L., Chiner, E., and Larramendi,C. H. Endobronchial tuberculosis in HIV-infected patients AIDS,9, 1159, 1995.

    Google Scholar 

  46. Schaaf, H. S., Gie, R. P., van Rie, A., Seifart, H. I., van Helden, P. D., and Cotton, M. F. Second episode of tuberculosis in an HIV-infected child: relapse or reinfection? J. Infect., 41, 100–103, 2000.

    Article  PubMed  CAS  Google Scholar 

  47. Dronda, F., Fernandez-Martin, I., Chaves, F., and Gonzalez-Lopez, M. Recurrent Mycobacterium tuberculosis bacteremia in AIDS: subtherapeutic concentrations of antitubercular agents? Med. Clin. (Barcelona), 103, 478, 1994.

    CAS  Google Scholar 

  48. Godfrey-Faussett, P., Githui, W., Batchelor, B., et al. Recurrence of HIV- related tuberculosis in an endemic area may be due to relapse or reinfection. Tuber. Lung Dis., 75, 199, 1994.

    Article  PubMed  CAS  Google Scholar 

  49. Small, P. M., Shafer, R. W., Hopewell, P. C., et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N. Engl. J. Med., 328, 1137, 1993; [see also comments in N. Engl. J. Med., 329, 811, 812, 1993 ].

    Google Scholar 

  50. Ashley, E. A., Johnson, M. A., and Lipman, M. C. Human immunodeficiency virus and respiratory infection. C.rr. Opin. Pulm. Med., 6, 240–245, 2000.

    Article  CAS  Google Scholar 

  51. Mahmoudi, A. and Iseman, D. Pitfalls in the care of patients with tuberculosis: common errors and their association with the acquisition of drug resistance. J. Am. Med. Assoc., 270, 65, 1993.

    Article  CAS  Google Scholar 

  52. Van Scoy, R. E. and Wilkowske, C. J. Antimycobacterial therapy. Mayo Clin. Proc., 74, 1038–1048, 1999.

    Google Scholar 

  53. Georgiev, V. St. Treatment and developmental therapeutics of Mycobacterium tuberculosis infections. Int. J. Antimicrob. Agents, 4, 157, 1994.

    Article  Google Scholar 

  54. Committee on Infectious Diseases. Chemotherapy for tuberculosis in infants and children. Pediatrics 89, 161, 1992.

    Google Scholar 

  55. Blom-Bülow, B. Dosing regimens in the treatment of tuberculosis. Scand. J. Infect. Dis. Suppl., 74, 258, 1990.

    Google Scholar 

  56. Doganay, M., Calangu, S., Turgut, H., Bakir, M., and Aygen, B. Treatment of tuberculous meningitis in Turkey. Scand. J. Infect. Dis., 27, 135, 1995.

    Article  PubMed  CAS  Google Scholar 

  57. Ibanez, S. and Ross, G. Quimioterapia abreviada de 6 meses en tuberculosis pulmonar infantil. Rev. Chil. Pediatr., 51, 249, 1980.

    Google Scholar 

  58. Anane, T., Cernay, J., and Bensenovci, A. Resultats compares des regimens et des regimens long dans la chimiotherapie de la tuberculose de l’ enfant en Algerie, African Regional Meeting of International Union Against Tuberculosis, Tunis, Tunisia, 1984.

    Google Scholar 

  59. Varudkar, B. L. Short-course chemotherapy for tuberculosis in children. Indian J. Pediatr, 52, 593, 1985.

    Article  PubMed  CAS  Google Scholar 

  60. Pelosi, F., Budani, H., Rubinstein, C., et al. Isoniazid, rifampin and pyrazinamide in the treatment of childhood tuberculosis with duration adjusted to the clinical status. Am. Rev. Respir. Dis., 131 (Suppl.), A229, 1985.

    Google Scholar 

  61. Starke, J. R. and Taylor-Watts, K. T. Six-month chemotherapy of intrathoracic tuberculosis in children. Am. Rev. Respir. Dis., 139 (Suppl.), A314, 1989.

    Google Scholar 

  62. Medical Research Council Tuberculosis and Chest Disease Unit. Management and outcome of chemotherapy for childhood tuberculosis. Arch. Dis. Child., 64, 1004, 1989.

    Article  Google Scholar 

  63. Biddulph, J. Short-course chemotherapy for childhood tuberculosis. Pediatr. Infect. Dis. J., 9, 794, 1990.

    Article  PubMed  CAS  Google Scholar 

  64. Khubchandani, R. P., Kumta, N. B., Bharucha, N. B., and Ramakantan, R. Short-course chemotherapy in childhood pulmonary tuberculosis. Am. Rev. Resp. Dis., 141 (Suppl.), A338, 1990.

    Google Scholar 

  65. Kumar, L., Dhand, R., Singhi, P. D, Rao, K. L., and Katariya, S. A randomized trial of fully intermittent vs. daily followed by intermittent short-course chemotherapy for childhood tuberculosis. Pediatr. Infect. Dis. J., 9, 802, 1990.

    Article  PubMed  CAS  Google Scholar 

  66. Wallis, R. S., Perkins, M. D., Phillips, M., et al. Predicting the outcome of therapy for pulmonary tuberculosis. Am. J. Respir. Crit. Care Med., 161 (4 Pt.1), 1076–1080, 2000.

    PubMed  CAS  Google Scholar 

  67. Small, P. M., Schecter, G. F., Goodman, P. C., et al. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N. Engl. J. Med., 324, 289, 1991.

    Article  PubMed  CAS  Google Scholar 

  68. Rose, D. N., Schechter, C. B., and Sacks, H. S. Preventive medicine for HIV-infected patients: an analysis of isoniazid prophylaxis for tuberculin reactors and for anergic patients. J. Gen. Intern. Med., 7, 589, 1992.

    Article  PubMed  CAS  Google Scholar 

  69. Pust, R. E., Tuberculosis in the 1990’s: resurgence, regimens, and resources. South. Med. J., 85, 584, 1992.

    Article  PubMed  CAS  Google Scholar 

  70. Cook, S. V., Fujiwara, P. I., and Frieden, T. R. Rates and risk factors for discontinuation of rifampicin.Int. J. Tuberc. Lung Dis.4, 118–122, 2000.

    Google Scholar 

  71. U.S. Public Health Service and Infectious Diseases Society of America. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Infect. Dis. Obstet. Gynecol., 5–74, 2000.

    Google Scholar 

  72. Centers for Disease Controls. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Morb. Mortal. Wkly Rep., 47 (RR-20), 1998.

    Google Scholar 

  73. Veldkamp, A. I., Hoetelmans, R. M., Beijinen, J. H., Mulder, J. W., and Meenhorst, P. L. Ritonavir enables combined therapy with rifampin and saquinavir. Clin. Infect. Dis., 29, 1586, 1999.

    Article  PubMed  CAS  Google Scholar 

  74. Riska, P. F., Jacobs, W. R. Jr., and Alland, D. Molecular determinants of drug resistance in tuberculosis. Int. J. Tuberc. Lung Dis., 4 (2 Suppl. 1), S4 — S10, 2000.

    PubMed  CAS  Google Scholar 

  75. Kuaban, C., Bercion, R., Jifon, G., Cunin, P., and Blackett, K. N. Acquired anti-tuberculosis drug resistance in Yaounde, Cameroon, Int. J. Tuberc. Lung Dis., 4, 427–432, 2000.

    PubMed  CAS  Google Scholar 

  76. Loiez-Durocher, C., Vachee, A., and Lamaitre, N. Drug resistance in Mycobacterium tuberculosis: diagnostic methods. Ann. Biol. Clin. (Paris), 58, 291–297, 2000.

    CAS  Google Scholar 

  77. Iseman, M. D. Treatment of multidrug-resistant tuberculosis. N. Engl. J. Med., 329, 784, 1993.

    Article  PubMed  CAS  Google Scholar 

  78. Weltman, A. C. and Rose, D. N. Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implication for initial therapeutic regimens at a New York City hospital. Arch. Intern. Med., 154, 2161, 1994.

    Article  PubMed  CAS  Google Scholar 

  79. Ouedraogo, M., Ouedraogo, S. M., Diagbouga, S., et al. Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis. Rev. Mal. Respir., 17, 477–480, 2000.

    PubMed  CAS  Google Scholar 

  80. Ausina, V., Riutort, N., Vinado, B., et al. Prospective study of drug-resistant tuberculosis in a Spanish urban population including patients at risk for HIV infection. Eur. J. Clin. Microbiol. Infect. Dis., 14, 105, 1995.

    Article  PubMed  CAS  Google Scholar 

  81. Nolan, C. M., Williams, D. L., Cave, M. D., et al. Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis. Am. J. Respir. Crit. Care Med., 152, 1067, 1995.

    PubMed  CAS  Google Scholar 

  82. Lutfey, M., Della-Latta, P., Kapur, V., et al. Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS. Am.J. Respir. Crit. Care Med.153, 837, 1996.

    PubMed  CAS  Google Scholar 

  83. Murray, J., Sonnenberg, P., Shearer, S., and Godfrey-Faussett, P. Drug-resistant pulmonary tuberculosis in a cohort of southern African gold miners with a high prevalence of HIV infection. S. Afr. Med. J., 90, 381–386, 2000.

    PubMed  CAS  Google Scholar 

  84. Churchyard, G. J., Corbett, E. L., Kleinschmidt, I., Mulder, D., and De Cock, K. M. Drug-resistant tuberculosis in South African gold miners: incidence and associated factors. Int. J. Tuberc. Lung Dis., 4, 433–440, 2000.

    PubMed  CAS  Google Scholar 

  85. Centers for Disease Controls. Report of the NIH Panel to define Principles of Therapy of HIV infection and guidelines for use of antiretroviral agents in HIV-infected adults and adolescents. Morb. Mortal. Wkly Rep., 47 (No. RR-5), 1998.

    Google Scholar 

  86. McNaghten, A. D., Hanson, D. L., Jones, J. L., Dworkin, M. S., Ward, J. W. and the Adult/Adolescent Spectrum of Disease group. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. AIDS, 13, 1687–1695, 1999.

    Article  Google Scholar 

  87. Kirk, O., Gatell, J. M., Mocroft, A., et al. Infections with Micobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy, EuroSIDA Study Group JD. Am. J. Respir. Crit. Care Med., 162 (3 pt. 1), 865–872, 2000.

    PubMed  CAS  Google Scholar 

  88. Essential components of a tuberculosis prevention and control program. Recommendation of the Advisory Council for the Elimination of Tuberculosis. Morb. Mortal. Wkly Rep., 44 (RR- 11), 1, 1995.

    Google Scholar 

  89. Stearn, B. F. and Polis, M. A. Prophylaxis of opportunistic infections in persons with HIV infection. Cleve. Clin. J. Med., 61, 187, 1994.

    PubMed  CAS  Google Scholar 

  90. Graham, N. M., Galai, N., Nelson, K. E., et al. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Arch. Intern. Dis., 156, 889, 1996.

    Article  CAS  Google Scholar 

  91. Holland, S. M. Cytokine therapy of mycobacterial infections. Adv. Intern. Med., 45, 431–452, 2000.

    PubMed  CAS  Google Scholar 

  92. Johnson, J. L., Kamya, R. M., Okwera, A., et al. Randomized controlled trial of Mycobacterium vaccae immunotherapy in nonhuman immunodeficiency virus-infected Ugandan adults with newly diagnosed pulmonary tuberculosis. The Ugandan-Case Western Reserve University Research Collaboration. J. Infect. Dis., 181, 1304–1312, 2000.

    Article  PubMed  CAS  Google Scholar 

  93. Tallat, A. M., Lyons, R., and Johnston, S. A. Towards therapeutic Mycobacterium tuberculosis vaccine using DNA microarray technology. Abstr. Gen. Meet. Am. Soc. Microbiol., May 30—June 3, 1999, 652, abstract U-98.

    Google Scholar 

  94. Howard, A., Li, Z., Kelley, C., Collins, F., and Morris, S. Protection and cytokine production associated with DNA vaccines against tuberculosis. Abstr. Gen. Meet. Am. Soc. Microbiol.,May 30—June 3, 1999, 651, abstract U-93.

    Google Scholar 

  95. Jagannath, C., Copenhanver, R., Armitige, L., et al. A mutant of Mycobacterium tuberculosis H37Rv deficient in antigen 85A expression, acts as vaccine against experimental tuberculosis in mice. Abstr. Gen. Meet. Am. Soc. Microbiol. May 30—June 3, 1999, 652, abstract U-96.

    Google Scholar 

  96. Waddell, R. D., Chintu, C., Lein, A. D., et al. Safety and immunogenicity of a five-dose series of inactivated Mycobacterium vaccae vaccination for the prevention of HIV-associated tuberculosis. Clin. Infect. Dis., 30(Suppl. 3 ), S309315, 2000.

    Google Scholar 

  97. Lein, A. D., Waddell, R. D., Chintu, C., et al. Phase I trial of Mycobacterium vaccae immunization in HIV infected and healthy adults in Lusaka, Zambia. 5th Conf Retroviruses Opportunistic Infect., Feb. 1–5, 1998, 217, abstract 736.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

    Vassil St. Georgiev PhD

Authors
  1. Vassil St. Georgiev PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Georgiev, V.S. (2003). Mycobacterium tuberculosis. In: Opportunistic Infections. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-296-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-296-8_8

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-303-9

  • Online ISBN: 978-1-59259-296-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation